Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics (VITAL-AF)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03515057 |
Recruitment Status : Unknown
Verified February 2021 by Steven A Lubitz, Massachusetts General Hospital.
Recruitment status was: Active, not recruiting
First Posted : May 3, 2018
Last Update Posted : February 24, 2021
|
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | April 22, 2018 | ||||
First Posted Date ICMJE | May 3, 2018 | ||||
Last Update Posted Date | February 24, 2021 | ||||
Actual Study Start Date ICMJE | July 31, 2018 | ||||
Actual Primary Completion Date | October 8, 2019 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
Incident AF during the study period [ Time Frame: 12-months ] The numerator of the outcome is the number of eligible patients with newly diagnosed AF during the study period. The eligible study population comprising the denominator will be assessed in two ways: (1) the whole population, defined as all patients aged 65 years and older presenting for an outpatient clinic appointment with a participating physician, nurse practitioner, or physician assistant at a study clinic during the enrollment period, and (2) the whole population excluding patients with an AF diagnosis prior to outcome assessment (prevalent AF).
|
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE |
|
||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics | ||||
Official Title ICMJE | Screening for Atrial Fibrillation in an Ambulatory Clinic Population: The VITAL-AF Study | ||||
Brief Summary | The overall goal of this study is to assess the effectiveness of screening for undiagnosed atrial fibrillation (AF) using simple, efficient, and portable electronic health and mobile technologies in a healthcare system. The investigators propose to perform population-based screening for undiagnosed AF as part of usual care in patients ≥ 65 years when their vital signs are checked (spot-check) at scheduled outpatient visits in adult Massachusetts General Hospital (MGH) primary care clinics. Patients will receive routine care by their primary care provider (PCP) based upon the results of the screening during the visit. The investigators hypothesize that rates of AF detection among individuals ≥ 65 years in the MGH primary care network will be greater among patients in clinics assigned to the spot-check arm compared to patients in clinics assigned to the usual care arm of the study. |
||||
Detailed Description | Not Provided | ||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Screening |
||||
Condition ICMJE | Atrial Fibrillation | ||||
Intervention ICMJE | Diagnostic Test: Single lead handheld electrocardiogram
Screening for atrial fibrillation during outpatient primary care office visits among patients 65 years and older
Other Name: AliveCor KardiaMobile EKG Monitor
|
||||
Study Arms ICMJE |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Unknown status | ||||
Actual Enrollment ICMJE |
35308 | ||||
Original Estimated Enrollment ICMJE |
35000 | ||||
Estimated Study Completion Date ICMJE | October 2021 | ||||
Actual Primary Completion Date | October 8, 2019 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 65 Years and older (Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | No | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT03515057 | ||||
Other Study ID Numbers ICMJE | CV185-581 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE |
|
||||
Current Responsible Party | Steven A Lubitz, Massachusetts General Hospital | ||||
Original Responsible Party | Same as current | ||||
Current Study Sponsor ICMJE | Massachusetts General Hospital | ||||
Original Study Sponsor ICMJE | Same as current | ||||
Collaborators ICMJE | University of Massachusetts, Worcester | ||||
Investigators ICMJE |
|
||||
PRS Account | Massachusetts General Hospital | ||||
Verification Date | February 2021 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |